Nanozymes as Enzyme Inhibitors
Yaling Huang,1 Jian Jiang,1 Yanqiu Wang,1 Jie Chen,1 Juqun Xi1,2 1Institute of Translational Medicine, Department of Pharmacology, School of Medicine, Yangzhou University, Yangzhou, Jiangsu, 225001, People’s Republic of China; 2Jiangsu Key Laboratory of Integrated Traditional Chinese and W...
Guardado en:
Autores principales: | Huang Y, Jiang J, Wang Y, Chen J, Xi J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0695065aa0494aed9f067a8d3aeed4d6 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Quantitative Insights Into β-Lactamase Inhibitor’s Contribution in the Treatment of Carbapenemase-Producing Organisms With β-Lactams
por: Yanfang Feng, et al.
Publicado: (2021) -
In-Vitro Selection of Ceftazidime/Avibactam Resistance in OXA-48-Like-Expressing <i>Klebsiella pneumoniae</i>: In-Vitro and In-Vivo Fitness, Genetic Basis and Activities of β-Lactam Plus Novel β-Lactamase Inhibitor or β-Lactam Enhancer Combinations
por: Snehal Palwe, et al.
Publicado: (2021) -
Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections
por: Gianluca Morroni, et al.
Publicado: (2021) -
Effect of freezing treatment of soybean on soymilk nutritional components, protein digestibility, and functional components
por: Meng‐jia Li, et al.
Publicado: (2021) -
Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection
por: Hu CMJ, et al.
Publicado: (2018)